Replies to post #671346 on NorthWest Biotherapeutics Inc (NWBO)

[georgebailey]

Agreed.Edit- btw, I forget if it was Doc or Atl, one of them had a nice chart showing patient volume relative to market cap. They did not use a 10 multiple on revenue I did.
I used 10, that is a premium multiple. I used 10 based on the premium economies of scale Eden’s enjoys and the growth potential of DCVax.
I would not use a 10 multiple on the Artisan method because of the lower volume produced and the expensive professional labor employed.
So at 12,000 patient capacity at Sawston, 200k per patient, that’s 2.4B in revenue and 24B in market cap….i like 20B.

[exwannabe]

Phase 1B is the other 7,500 f^2 (aprox) of the facility that Advent leases.

There is plenty of extra space available in the rest of the building, agreed.